BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31383285)

  • 1. Gemcitabine, vinorelbine and cyclooxygenase inhibitors in the treatment of glioblastoma. Ultrastructural analyses in C6 glioma in vitro.
    Elmaci İ; Bilir A; Ozpinar A; Altinoz MA
    Tissue Cell; 2019 Aug; 59():18-32. PubMed ID: 31383285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinorelbine's anti-tumor actions may depend on the mitotic apoptosis, autophagy and inflammation: hypotheses with implications for chemo-immunotherapy of advanced cancers and pediatric gliomas.
    Altinoz MA; Ozpinar A; Alturfan EE; Elmaci I
    J Chemother; 2018 Jul; 30(4):203-212. PubMed ID: 30025492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetaminophen and DMSO modulate growth and gemcitabine cytotoxicity in FM3A breast cancer cells in vitro.
    Bilir A; Guneri AD; Altinoz MA
    Neoplasma; 2004; 51(6):460-4. PubMed ID: 15640956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma.
    Voigt W; Kegel T; Weiss M; Mueller T; Simon H; Schmoll HJ
    J Cancer Res Clin Oncol; 2005 Sep; 131(9):585-90. PubMed ID: 16021466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of Gemcitabine and Vinorelbine on inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) distribution of MCF-7 breast cancer cells.
    Zeybek ND; Inan S; Ekerbicer N; Vatansever HS; Karakaya J; Muftuoglu SF
    Acta Histochem; 2011 Jan; 113(1):62-7. PubMed ID: 19796794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbine.
    Emmanouilides C; Jazirehi AR; Bonavida B
    Cancer Biother Radiopharm; 2002 Dec; 17(6):621-30. PubMed ID: 12537665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells.
    Zhang M; Boyer M; Rivory L; Hong A; Clarke S; Stevens G; Fife K
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):353-60. PubMed ID: 14751503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trial.
    Bajetta E; Chiara Stani S; De Candis D; Bidoli P; Mariani L; Zilembo N; Pozzi P; Procopio G
    Cancer; 2000 Aug; 89(4):763-8. PubMed ID: 10951338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.
    Curran MP; Plosker GL
    Drugs Aging; 2002; 19(9):695-721. PubMed ID: 12381238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancers.
    Arora M; Bogenberger JM; Abdelrahman AM; Yonkus J; Alva-Ruiz R; Leiting JL; Chen X; Serrano Uson Junior PL; Dumbauld CR; Baker AT; Gamb SI; Egan JB; Zhou Y; Nagalo BM; Meurice N; Eskelinen EL; Salomao MA; Kosiorek HE; Braggio E; Barrett MT; Buetow KH; Sonbol MB; Mansfield AS; Roberts LR; Bekaii-Saab TS; Ahn DH; Truty MJ; Borad MJ
    Hepatology; 2022 Jan; 75(1):43-58. PubMed ID: 34407567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.
    Gridelli C; Cigolari S; Gallo C; Manzione L; Ianniello GP; Frontini L; Ferraù F; Robbiati SF; Adamo V; Gasparini G; Novello S; Perrone F;
    Lung Cancer; 2001; 31(2-3):277-84. PubMed ID: 11165408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.
    Herbst RS; Lynch C; Vasconcelles M; Teicher BA; Strauss G; Elias A; Anderson I; Zacarola P; Dang NH; Leong T; Salgia R; Skarin AT
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):151-9. PubMed ID: 11561781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medroxyprogesterone effects on colony growth, autophagy and mitochondria of C6 glioma cells are augmented with tibolone and temozolomide: Cell kinetic and electron microscopical studies with a broad review of the literature.
    Elmaci İ; Ozpinar A; Bilir A; Altinoz MA
    Clin Neurol Neurosurg; 2019 Feb; 177():77-85. PubMed ID: 30622045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine in combination with vinorelbine for treatment of advanced breast cancer.
    Hortobagyi GN
    Clin Breast Cancer; 2002 May; 3 Suppl 1():34-8. PubMed ID: 12057044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multicenter, randomized, phase II study.
    Palmeri S; Lorusso V; Palmeri L; Vaglica M; Porta C; Nortilli R; Ferraú F; Comella G; Massidda B; Danova M;
    Cancer; 2006 Dec; 107(12):2898-905. PubMed ID: 17109447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Billings FT; Bradof JE; Baker M; Greco FA
    Cancer; 2001 Nov; 92(9):2391-8. PubMed ID: 11745295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older.
    Chen YM; Perng RP; Chen MC; Tsai CM; Ming-Liu J; Whang-Peng J
    Lung Cancer; 2003 May; 40(2):221-6. PubMed ID: 12711125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy.
    Chen YM; Perng RP; Lee CS; Lin WC; Tsai CM; Whang-Peng J
    Am J Clin Oncol; 2003 Dec; 26(6):567-70. PubMed ID: 14663373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.
    Juergens R; Brahmer J; Ettinger D
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):621-9. PubMed ID: 16937106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.